Codiak Biosciences Competitors and Similar CompaniesClear all
Nimbus Therapeutics's competitors and similar companies include Takeda and ArunA Bio.
 Nimbus Therapeutics Nimbus Therapeutics is a biotechnology company which operates an application of computational chemistry to design treatments for substantial and underserved human diseases. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  ArunA Bio ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules. | |
Founding Date | Founding Date 2009 | Founding Date 1781 | Founding Date 2003 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Cambridge, US HQ | Locations Athens, US HQ Athens, US | |
Employees | Employees 1091% increase | Employees 47,4554% decrease | Employees 274% increase |
Funding | |||
Latest funding round | Latest funding round $ 105m (almost 5 years ago) | Latest funding round N/A | Latest funding round $ 4.5m (over 6 years ago) |
Total funding raised | Total funding raised $ 242m | Total funding raised $ 57.8m | Total funding raised $ 26.9m |
For sources of this data, please see the company profile
View Company Profiles
Takeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyArunA Bio
HQ
Athens, US
Employees
27↑ 4% increase
ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules.
View company